Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Eloralintide for Sale > Eloralintide, LY3841136, 2883634-40-8
Eloralintide, LY3841136, 2883634-40-8 buy - large image1
Eloralintide, LY3841136, 2883634-40-8 buy - image1

Eloralintide, LY3841136, 2883634-40-8

83 Inquiries

Unit Price:

$1000-1200/G FOB

Get Latest Price
CAS No.:

2883634-40-8

Grade:

Reagent Grade

Content:

98%

Port:

shanghai

Brand:

cellmano

Packaging:

1g

Price valid (until):

2029-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    CAT#:PEP108

    Product Name : Eloralintide

    Synonyms: LY3841136

    CAS#: 2883634-40-8

    Molecular Formula: C201H319N49O65S2

    MW: 4526.10

    Sequence:H-γ-Glu-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gly-Orn-Leu-Ala-Glu-(α-Me-Phe)-Leu-Val-Arg-Ser-Ser-Asn-(N-Me-Asn)-Phe-Gly-Pro-Lys(γGlu-γGlu-C20 diacid)-Leu-Pro-Pro-Thr-Glu-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (Disulfide bridge:Cys2-Cys7)

    Appearance: white powder

    Purity (HPLC):≥98.0%

    Single Impurity (HPLC): ≤1.0%

    Acetate Content(HPLC):≤12.0%

    Water Content (Karl Fischer): ≤10.0%

    Peptide content: ≥80.0%

    Package:1g-1kg in plastic bottle

    Storage:2-8 degree, store in dry and cool place

    Usage: used for R&D only

    Shop Eloralintide, LY3841136, 2883634-40-8-Detailed Image 1

    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide

    Location:

    Room C608, Chiyuan venture park

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

        Cellmano Biotech Limited focus on researching and developing solid phase peptide synthesis methodology since 2011. Cellmano has 10 years experience in researching, developing and manufacturing peptides by solid peptide phase synthesis. 
        Cellmano  not only provides  cosmeceuticals peptide & generic peptides to the customers, but also offer peptide CMO service and custom peptides synthesis service depend on the requirement from the customers over the world. Cellmano has state-of-the-art labs armed with excellent instrument for synthesis, purify and analysis .Cellmao control the quality by checking the materials, supervising produce process and finally QC. Cellmano keep all the synthesis records , purify methods and analysis result for every batch peptide product with staff and time invovled in the archives. Synthesizing by classical solid phase mothed invented by Prof.Bruce Merrified and purifying by HPLC instrument, Cellmano supply the customers excellent peptide products with reasonable price ,while maintain high quality, to help the customers to cut down their cost and shorten the time . Cellmano is trying her best to complement the inventory  for more than 2000 popular peptide products, to make sure the customers can get what they need in one week from Cellmano’s inventory. Also to saitisfy diverse request from different customers for different projects, Cellmano provide custom synthesis for  peptides from mgs to kgs with the purity from crude to 98% .


  • Inquiry History
    83 Inquiries
    Country Product Purchase Quantity Date Posted
    Germany

    Eloralintide, Lyophilised (Freeze-Dried) Peptides – High Purity / Low Endotoxin (LPS Removed)

    100  Oct 26, 2026
    United States

    Eloralintide (LY-3841136)

    1  Oct 24, 2026
    Netherlands

    Eloralintide

    10 MG Oct 22, 2026
    France

    eloralintide

    1 MT Oct 21, 2026
    South Korea

    Eloralintide

    1 G Oct 21, 2026
    United States

    Eloralintide

    10 PCS Oct 21, 2026
    United Kingdom

    Eloralintide

    100 PCS Oct 20, 2026
    United States

    Eloralintide

    20 MG Oct 19, 2026
    United States

    Eloralintide

    1 MT Oct 16, 2026
    United States

    Eloralintide

    10 MT Oct 10, 2026
    Germany

    Eloralintide

    1 PCS Oct 10, 2026
    United States

    eloralintide

    10 MG Oct 6, 2026
    United States

    Eloralintide

    10 MG Oct 5, 2026
    United Kingdom

    Eloralintide vials

    5 PCS Oct 4, 2026
    Australia

    ELORALINTIDE

    10 PCS Oct 2, 2026
    Brazil

    Eloralintide

    5 MT Oct 2, 2026
    Australia

    Eoralintide

    10 PCS Oct 1, 2026
    United Kingdom

    Eloralitide

    2 G Sep 27, 2026
    United Kingdom

    Eloralintide

    30 MG Sep 22, 2026
    United States

    Eloralintids

    10 MG Sep 18, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.